(0.22%) 5 111.42 points
(0.36%) 38 376 points
(0.26%) 15 969 points
(-1.41%) $82.67
(5.77%) $2.03
(0.17%) $2 351.20
(-0.01%) $27.53
(3.91%) $958.15
(-0.25%) $0.932
(-0.37%) $10.98
(-0.56%) $0.796
(1.67%) $93.41
1.13% $ 66.67
Live Chart Being Loaded With Signals
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems...
Stats | |
---|---|
Tagesvolumen | 7 709.00 |
Durchschnittsvolumen | 31 390.00 |
Marktkapitalisierung | 239.26M |
EPS | $0 ( 2024-04-25 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-07-23 |
Last Dividend | $0.300 ( 2023-12-14 ) |
Next Dividend | $0 ( N/A ) |
P/E | 14.59 |
ATR14 | $0.0890 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-27 | Koopman Brian | Buy | 500 | Employee Stock Option - Right to Buy |
2023-06-15 | Koopman Brian | Sell | 60 | Common Stock |
2023-05-18 | Richins Paul O | Sell | 700 | Common Stock |
2023-03-17 | Richins Paul O | Sell | 150 | Common Stock |
2023-02-08 | Payne Barbara A | Sell | 500 | Common Stock |
INSIDER POWER |
---|
-23.00 |
Last 100 transactions |
Buy: 7 349 | Sell: 108 142 |
Utah Medical Products Inc Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Utah Medical Products Inc Finanzdaten
Annual | 2023 |
Umsatz: | $50.22M |
Bruttogewinn: | $24.35M (48.47 %) |
EPS: | $4.58 |
FY | 2023 |
Umsatz: | $50.22M |
Bruttogewinn: | $24.35M (48.47 %) |
EPS: | $4.58 |
FY | 2022 |
Umsatz: | $52.28M |
Bruttogewinn: | $32.20M (61.58 %) |
EPS: | $4.53 |
FY | 2021 |
Umsatz: | $49.05M |
Bruttogewinn: | $30.92M (63.03 %) |
EPS: | $4.15 |
Financial Reports:
No articles found.
Utah Medical Products Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.290 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.295 (N/A) |
$0.300 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.150 | 2004-06-14 |
Last Dividend | $0.300 | 2023-12-14 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-03 | |
Next Payout Date | N/A | |
# dividends | 79 | -- |
Total Paid Out | $21.80 | -- |
Avg. Dividend % Per Year | 1.09% | -- |
Score | 4.57 | -- |
Div. Sustainability Score | 5.77 | |
Div.Growth Potential Score | 6.55 | |
Div. Directional Score | 6.16 | -- |
Year | Amount | Yield |
---|---|---|
2004 | $0.450 | 1.75% |
2005 | $0.630 | 2.84% |
2006 | $0.780 | 2.55% |
2007 | $0.885 | 2.68% |
2008 | $0.905 | 3.06% |
2009 | $0.925 | 3.86% |
2010 | $1.665 | 5.63% |
2011 | $0.945 | 3.50% |
2012 | $0.965 | 3.53% |
2013 | $0.985 | 2.57% |
2014 | $1.005 | 1.94% |
2015 | $1.025 | 1.77% |
2016 | $1.045 | 1.78% |
2017 | $1.065 | 1.49% |
2018 | $1.085 | 1.37% |
2019 | $1.105 | 1.30% |
2020 | $1.125 | 1.05% |
2021 | $2.86 | 3.41% |
2022 | $1.165 | 1.20% |
2023 | $1.185 | 1.21% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.334 | 1.500 | 3.32 | 4.98 | [0 - 0.5] |
returnOnAssetsTTM | 0.121 | 1.200 | 5.97 | 7.16 | [0 - 0.3] |
returnOnEquityTTM | 0.131 | 1.500 | 9.66 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.261 | -1.000 | 7.39 | -7.39 | [0 - 1] |
currentRatioTTM | 19.57 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 17.79 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | -17.14 | 1.500 | -10.00 | -10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.14 | 2.00 | 7.95 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.96 | 2.00 | 7.02 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.573 | 1.000 | 3.79 | 3.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.331 | 1.000 | 5.39 | 5.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.362 | 0.800 | -0.919 | -0.735 | [0.5 - 2] |
Total Score | 5.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.61 | 1.000 | 8.63 | 0 | [1 - 100] |
returnOnEquityTTM | 0.131 | 2.50 | 9.78 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.96 | 2.00 | 8.01 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.805 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.14 | 2.00 | 7.95 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.261 | 1.500 | 7.39 | -7.39 | [0 - 1] |
pegRatioTTM | 1.429 | 1.500 | 3.80 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.454 | 1.000 | 1.142 | 0 | [0.1 - 0.5] |
Total Score | 6.55 |
Utah Medical Products Inc
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.